ClinicalTrials.gg
TerminatedNCT01100515Updated Apr 9, 2010

Hyperbaric Oxygen Therapy for Acute Domestic Carbon Monoxide (CO) Poisoning

A Phase 3 interventional study of normobaric oxygen therapy and Hyperbaric oxygen therapy in Carbon Monoxide Poisoning, sponsored by University of Versailles. Terminated at 1 site in France. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2010-04-09.

Sponsored by University of Versailles · Phase 3, Interventional, and Treatment

Why this study was terminated
this study was suspended for futility
Phase
Phase 3
Study type
Interventional
Enrollment
179
Allocation
Randomized
Ages
15 Years and older
Sex
All
01

Study summary

Carbon monoxide poisoning still places a burden on the healthcare system worldwide. While oxygen therapy is the cornerstone treatment, the role and practical modalities of hyperbaric oxygen therapy (HBO) remain controversial. This study aimed at comparing one session of HBO at 2 absolute atmosphere followed by 4 hours of normobaric oxygen therapy to 6 hours of normobaric oxygen therapy in adult victims of acute domestic carbon monoxide poisoning and without coma.

02

Conditions studied

  • Carbon Monoxide Poisoning

Keywords

  • intoxication
  • carbon monoxide
  • adults
  • domestic accident
  • acute domestic carbon monoxide poisoning
03

In context

Carbon Monoxide Poisoning

43 studies on the registry are indexed under Carbon Monoxide Poisoning; 8 are open to participants now.

This study's enrollment of 179 is above the median of 75 across 15 interventional studies indexed under Carbon Monoxide Poisoning.

Browse Carbon Monoxide Poisoning studies →

Lead sponsor

University of Versailles is the lead sponsor of 15 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients older than 15 years of age
  • admitted for domestic CO poisoning within 12 hours after the end of CO exposure.
  • had transient loss of consciousness (syncope, malaise)
  • carboxyhemoglobin level at presentation >10% or 5%, in smokers and non-smokers, respectively.

Exclusion criteria

Exclusion Criteria:

  • poisoning by more than one compound (e.g., CO plus a drug or CO plus other toxic gases such as those found in fire smoke
  • suicide attempt
  • pregnancy
  • coma
  • contraindications to HBO (circulatory collapse or pneumothorax)
  • technical obstacles to HBO
  • non domestic CO poisoning
  • difficulty in determining whether the patient experienced initial loss of consciousness or initial coma
  • consent refusal.
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
179 participants (actual)

Study arms

  • Experimental
    Experimental arm

    Hyperbaric oxygen therapy at 2 absolute atmosphere (1-hour plateau) followed by 4 hours of normobaric oxygen therapy

    Other: Hyperbaric oxygen therapy

  • Active comparator
    Control

    6 hours course of normobaric oxygen therapy via a face full mask

    Other: normobaric oxygen therapy

Interventions

  • Othernormobaric oxygen therapy

    oxygen therapy was delivered via a full face mask at high flow to achieve 100% of inspired oxygen fraction

  • OtherHyperbaric oxygen therapy

    Hyperbaric oxygen therapy was delivered in a hyperbaric chamber, pressurized at 2 absolute atmosphere (1 hour plateau) and the patient breathed high oxygen concentration via a full face mask followed by 4 hours of normobaric oxygen therapy

06

What researchers measure

Primary outcomes

  1. full recovery

    Full recovery was defined as an absence of symptoms reported on the self-assessment questionnaire with a normal physical exam (including normal neuropsychological functions).

    Time frame: at one month

Secondary outcomes

  1. persistent neurological sequels

    Neurological sequels were considered persistent (PNS) if they were present both at hospital discharge and at one-month evaluation, regardless of the type of manifestation

    Time frame: at one month

  2. delayed neurological sequels

    Delayed neurological sequelae (DNS) were any neurological manifestations that appeared between hospital discharge and one-month evaluation, regardless of their severity. Patients with DNS were those considered fully recovered at hospital discharge but with neurological manifestations at one-month evaluation

    Time frame: at one month

  3. variations in carboxyhemoglobin levels

    the difference in serum carboxyhemoglobin levels between baseline values and values recorded immeadiately after study treatment completion

    Time frame: at 12 hours from randomization

  4. serious adverse events

    any complications of hyperbaric oxygen therapy

    Time frame: at one month

07

Study locations

1 site
  • Raymond Poincaré Hospital
    Garches, 92380, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01100515
Lead sponsor
University of Versailles
First posted
Apr 9, 2010
Start date
Oct 1989
Primary completion
Jan 2000
Completion
Feb 2000
Last update
Apr 9, 2010

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion